Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of biochemical recurrence after primary focal cryosurgery (hemiablation) for localized prostate cancer: A multi-institutional analytic comparison of Phoenix and Stuttgart criteria.
Kongnyuy M, Lipsky MJ, Islam S, Robins DJ, Hager S, Halpern DM, Kosinski KE, Schiff JT, Corcoran AT, Wenske S, Katz AE. Kongnyuy M, et al. Among authors: schiff jt. Urol Oncol. 2017 Aug;35(8):530.e15-530.e19. doi: 10.1016/j.urolonc.2017.03.016. Epub 2017 Apr 11. Urol Oncol. 2017. PMID: 28410986
Patient-reported quality of life progression in men with prostate cancer following primary cryotherapy, cyberknife, or active holistic surveillance.
Werneburg GT, Kongnyuy M, Halpern DM, Salcedo JM, Kosinski KE, Haas JA, Schiff JT, Corcoran AT, Katz AE. Werneburg GT, et al. Among authors: schiff jt. Prostate Cancer Prostatic Dis. 2018 Sep;21(3):355-363. doi: 10.1038/s41391-017-0004-y. Epub 2017 Dec 7. Prostate Cancer Prostatic Dis. 2018. PMID: 29217830 Free PMC article.
Effects of Focal vs Total Cryotherapy and Minimum Tumor Temperature on Patient-reported Quality of Life Compared With Active Surveillance in Patients With Prostate Cancer.
Werneburg GT, Kongnyuy M, Halpern DM, Salcedo JM, Chen C, LeSueur A, Kosinski KE, Schiff JT, Corcoran AT, Katz AE. Werneburg GT, et al. Among authors: schiff jt. Urology. 2018 Mar;113:110-118. doi: 10.1016/j.urology.2017.10.054. Epub 2017 Dec 23. Urology. 2018. PMID: 29277657 Free PMC article.
The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial.
Chughtai B, Elterman D, Shore N, Gittleman M, Motola J, Pike S, Hermann C, Terrens W, Kohan A, Gonzalez RR, Katz A, Schiff J, Goldfischer E, Grunberger I, Tu LM, Alshak MN, Kaminetzky J. Chughtai B, et al. Urology. 2021 Jul;153:270-276. doi: 10.1016/j.urology.2020.12.022. Epub 2020 Dec 26. Urology. 2021. PMID: 33373708 Clinical Trial.
An Evaluation of Sexual Function in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men Treated with the Temporarily Implanted Nitinol Device.
Elterman D, Alshak MN, Martinez Diaz S, Shore N, Gittleman M, Motola J, Pike S, Hermann C, Terens W, Kohan A, Gonzalez R, Katz A, Schiff J, Goldfischer E, Grunberger I, Tu L, Kaminetsky J, Chughtai B. Elterman D, et al. J Endourol. 2023 Jan;37(1):74-79. doi: 10.1089/end.2022.0226. Epub 2022 Oct 3. J Endourol. 2023. PMID: 36070450 Free PMC article. Clinical Trial.
14 results